BioLife Solutions Announces Changes to Board of Directors
BOTHELL, Wash., July 14, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS)("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced changes to its board of directors.
- BOTHELL, Wash., July 14, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS)("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced changes to its board of directors.
- His experience, mentorship and board leadership have been instrumental in helping craft our strategy and drive our growth at BioLife."
- Current Chief Executive Officer and director, Mike Rice, has been appointed by the board of directors as the new chairman.
- BioLife Solutions is a leading supplier of cell and gene therapy bioproduction products and services.